The federal Liberal government's COVID-19 vaccine manufacturing policy is facing yet another challenge after Maryland-based Novavax announced late Tuesday it may not have enough cash in a year's time to stay in business.
Ailing killer whale off B.C. coast diagnosed with parasitic wormsNunavut cruise ship rescue leaves taxpayers on the hook for over $500KThe 'no American food' diet — How an Ontario man ate only local food all summerNew study predicts 'radical re-shaping' of Arctic landscape by end of centuryCanadian military to severely curtail use of recreational marijuana
0 comments:
Post a Comment